Edward A. Swabb
Edward A. Swabb publishes mostly in Pharmacology, Molecular Biology and Physiology, on topics such as Antibiotics Pharmacokinetics and Efficacy, Cholinesterase and Neurodegenerative Diseases and Analytical Methods in Pharmaceuticals.
- World rank
- #1,103,963 of 7,710,434 ranked researchers
- Rank in United States
- #357,120 of 1,627,098
- Works
- 72
- Citations
- 2.7k
- Citations per work
- 37.1
What does Edward A. Swabb research?
Edward A. Swabb's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (7%), Chemistry (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3751.1%
- Health Sciences2738.1%
- Medicine2738.1%
- Life Sciences56.7%
- Physical Sciences34.1%
- Chemistry34.1%
- 1Pharmacology24% of their works
- 2Molecular Biology7% of their works
- 3Physiology6% of their works
- 4Epidemiology4% of their works
- 5Pediatrics, Perinatology and Child Health4% of their works
- 6Analytical Chemistry4% of their works
Research topics
- Antibiotics Pharmacokinetics and Efficacy
- Cholinesterase and Neurodegenerative Diseases
- Analytical Methods in Pharmaceuticals
- Pharmacogenetics and Drug Metabolism
- Antibiotic Resistance in Bacteria
- Alzheimer's disease research and treatments
- Computational Drug Discovery Methods
- Pharmacological Effects and Toxicity Studies
Which keywords describe Edward A. Swabb's research?
The keywords of their largest research topics: Antibiotic Pharmacokinetics, Critically Ill Patients, Acetylcholinesterase, Cholinesterase Inhibitors, Pharmacokinetics, Oxidative Stress, Green Analytical Chemistry and Pharmaceutical Analysis.
- Virtual Screening
- Molecular Docking
- Tau Pathology
- Antibiotic Resistance
- Pharmacogenetics
- Pharmaceutical Analysis
- Oxidative Stress
- Cholinesterase Inhibitors
- Critically Ill Patients
- Antibiotic Pharmacokinetics
- Acetylcholinesterase
- Pharmacokinetics
- Green Analytical Chemistry
- Cytochrome P450
- Amyloid Hypothesis
- Multidrug-Resistant Bacteria
- Antiepileptic Drugs
- Prenatal Exposure
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Antibiotic Pharmacokinetics211 topic
- Critically Ill Patients211 topic
- Acetylcholinesterase161 topic
- Cholinesterase Inhibitors161 topic
- Pharmacokinetics122 topics
- Oxidative Stress112 topics
- Green Analytical Chemistry81 topic
- Pharmaceutical Analysis81 topic
- Cytochrome P45071 topic
- Pharmacogenetics71 topic
- Amyloid Hypothesis61 topic
- Antibiotic Resistance61 topic
- Multidrug-Resistant Bacteria61 topic
- Tau Pathology61 topic
- Antiepileptic Drugs51 topic
- Molecular Docking51 topic
- Prenatal Exposure51 topic
- Virtual Screening51 topic
Where does Edward A. Swabb work?
Edward A. Swabb's main affiliation in the publication record is Myriad Genetics, United States.
How many publications and citations does Edward A. Swabb have?
OpenAlex counts 72 works and 2,674 citations for Edward A. Swabb, an h-index of 28, ranking #1,103,963 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Edward A. Swabb. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.